1. Home
  2. ZDAI vs HBIO Comparison

ZDAI vs HBIO Comparison

Compare ZDAI & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZDAI
  • HBIO
  • Stock Information
  • Founded
  • ZDAI 2022
  • HBIO 1901
  • Country
  • ZDAI Hong Kong
  • HBIO United States
  • Employees
  • ZDAI N/A
  • HBIO N/A
  • Industry
  • ZDAI General Bldg Contractors - Nonresidential Bldgs
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • ZDAI Consumer Discretionary
  • HBIO Industrials
  • Exchange
  • ZDAI Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • ZDAI 20.6M
  • HBIO 24.6M
  • IPO Year
  • ZDAI 2024
  • HBIO 2000
  • Fundamental
  • Price
  • ZDAI $0.60
  • HBIO $0.56
  • Analyst Decision
  • ZDAI
  • HBIO Buy
  • Analyst Count
  • ZDAI 0
  • HBIO 2
  • Target Price
  • ZDAI N/A
  • HBIO $3.00
  • AVG Volume (30 Days)
  • ZDAI 60.7K
  • HBIO 1.4M
  • Earning Date
  • ZDAI 08-15-2025
  • HBIO 08-11-2025
  • Dividend Yield
  • ZDAI N/A
  • HBIO N/A
  • EPS Growth
  • ZDAI N/A
  • HBIO N/A
  • EPS
  • ZDAI N/A
  • HBIO N/A
  • Revenue
  • ZDAI $17,166,534.00
  • HBIO $91,397,000.00
  • Revenue This Year
  • ZDAI N/A
  • HBIO N/A
  • Revenue Next Year
  • ZDAI N/A
  • HBIO $9.75
  • P/E Ratio
  • ZDAI $19.05
  • HBIO N/A
  • Revenue Growth
  • ZDAI 56.11
  • HBIO N/A
  • 52 Week Low
  • ZDAI $0.37
  • HBIO $0.28
  • 52 Week High
  • ZDAI $107.36
  • HBIO $3.45
  • Technical
  • Relative Strength Index (RSI)
  • ZDAI N/A
  • HBIO 64.20
  • Support Level
  • ZDAI N/A
  • HBIO $0.39
  • Resistance Level
  • ZDAI N/A
  • HBIO $0.64
  • Average True Range (ATR)
  • ZDAI 0.00
  • HBIO 0.04
  • MACD
  • ZDAI 0.00
  • HBIO 0.01
  • Stochastic Oscillator
  • ZDAI 0.00
  • HBIO 69.88

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: